Spectrum of EEG abnormalities during clozapine treatment

Electroencephalography and Clinical Neurophysiology
B A MalowD Pickar

Abstract

Clozapine is a novel antipsychotic agent effective in treating refractory schizophrenia. Clozapine produces fewer extrapyramidal effects than other neuroleptics, although agranulocytosis and seizures are significant adverse effects. To characterize the spectrum of clozapine-related electroencephalographic abnormalities, we identified 10 patients who had electroencephalograms (EEGs) performed before and during clozapine treatment. These 10 patients represented a subset of individuals participating in an investigational trial. During clozapine treatment, five developed myoclonus and one experienced a generalized tonic-clonic seizure. Records were retrospectively reviewed by an electroencephalographer blinded to the patient's history and medications. All patients had normal EEGs before clozapine treatment. While receiving clozapine (250-900 mg daily), all patients developed background slowing in the theta and often delta ranges. Additionally, 7 patients exhibited bilateral spike, polyspike and slow wave discharges, one with a photoparoxysmal response. Follow-up EEGs performed in 4 of these 7 patients after a decrease in clozapine dosage and/or addition in valproic acid showed diminished epileptiform activity.

References

Mar 14, 1991·The New England Journal of Medicine·R J Baldessarini, F R Frankenburg
Jan 1, 1991·European Archives of Psychiatry and Clinical Neuroscience·E GouzoulisU von Bardeleben
Aug 15, 1991·The New England Journal of Medicine·L J FriedmanM Sved
Mar 1, 1991·Neurology·O DevinskyJ Patin
Jan 1, 1985·Epilepsia·M Hallett
Aug 1, 1965·Proceedings of the Society for Experimental Biology and Medicine·R A Gortner, J B Ekwurtzel
Oct 1, 1993·Brain Pathology·H K Wolf, O D Wiestler
Sep 30, 1993·Nature·P SeemanH H Van Tol
Feb 28, 2002·Expert Opinion on Investigational Drugs·Ece A MutluAli Keshavarzian

❮ Previous
Next ❯

Citations

May 1, 1996·Schizophrenia Research·P B VrtunskiG J Jaskiw
Nov 5, 1997·Biological Psychiatry·J R StevensP Szot
Nov 24, 1998·Schizophrenia Research·P B VrtunskiG Jurjus
Oct 29, 2003·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Christian WienbruchBrigitte Rockstroh
Jun 21, 2005·Clinical Neuropharmacology·Ana CamachoEva Pomares
Jul 23, 1999·Annals of the New York Academy of Sciences·J R Stevens
Jan 20, 2004·CNS Drugs·Félix Javier Jiménez-JiménezMaría de Toledo-Heras
Feb 3, 2004·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·M WeisbrodH H Stassen
Oct 17, 2009·Progress in Neuro-psychopharmacology & Biological Psychiatry·Samir Kumar PraharajVinod Kumar Sinha
Sep 16, 2009·Progress in Neuro-psychopharmacology & Biological Psychiatry·Tracy ButlerDonna T Anthony
Feb 6, 2015·Acta neurologica Belgica·Irman ChaychiAshkan Chaichi
May 4, 2011·Acta Psychiatrica Scandinavica·J NielsenD Taylor
Jul 6, 2004·Journal of Ethnopharmacology·Luciane Costa-CamposElaine Elisabetsky
Nov 15, 1995·Biological Psychiatry·D Hinze-SelchT Pollmächer
Jul 15, 1997·Biological Psychiatry·O FreudenreichJ P McEvoy
Sep 13, 2014·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Maryam RavanAhmad Khodayari-Rostamabad
Dec 27, 2011·Epilepsy Research·Jennifer Block RosenSheryl R Haut
Dec 30, 2014·CNS Drugs·Andrew M Williams, Susie H Park
Nov 3, 2010·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Ahmad Khodayari-RostamabadHubert de Bruin
Oct 25, 2016·Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology·Nilamadhab KarRahul Chandavarkar
Feb 3, 2016·Therapeutic Advances in Psychopharmacology·Ian J Osborne, Ronan J McIvor
Apr 1, 2011·Therapeutic Advances in Psychopharmacology·Seema VarmaDavid Taylor
May 28, 2010·Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society·William O TatumSelim R Benbadis
Jan 5, 2012·Psychiatry Investigation·Nishant GoyalHaque Nizamie
Feb 23, 2020·Journal of Pharmacy Practice·Allison SchmitzMorris Hund
Aug 11, 2007·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Jason Wong, Nicholas Delva
Jan 1, 1998·International Journal of Psychiatry in Clinical Practice·E TanerE Işik

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here